EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sci Pharmtech's enterprise value is NT$11,018 Mil.
Sci Pharmtech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1,172 Mil. Therefore, Sci Pharmtech's EV-to-Revenue for today is 9.40.
The historical rank and industry rank for Sci Pharmtech's EV-to-Revenue or its related term are showing as below:
TPE:4119'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.25 Med: 3.41 Max: 13.07
Current: 9.4
During the past 13 years, the highest EV-to-Revenue of Sci Pharmtech was 13.07. The lowest was 2.25. And the median was 3.41.
TPE:4119's EV-to-Revenue is ranked worse than 87.01% of 1024
companies
in the Drug Manufacturers industry
Industry Median: 2.285
vs TPE:4119: 9.40
As of today (2024-05-26), Sci Pharmtech's stock price is NT$91.90.
Sci Pharmtech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$10.16. Therefore, Sci Pharmtech's PS Ratio for today is 9.05.
Sci Pharmtech EV-to-Revenue Historical Data
The historical data trend for Sci Pharmtech's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sci Pharmtech's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sci Pharmtech's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Sci Pharmtech's EV-to-Revenue falls into.
Sci Pharmtech's current Enterprise Value is NT$11,018 Mil.
Sci Pharmtech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,172 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sci Pharmtech's share price for today is NT$91.90.
Sci Pharmtech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$10.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sci Pharmtech EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Sci Pharmtech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TPE:4119 has been successfully added to your 